Phenomix Sciences

Phenomix Sciences is a biotechnology company founded in 2017 and based in New York, specializing in precision medicine for obesity management. The company has developed a data analysis platform that includes a novel blood test, supported by an AI-driven algorithm. This technology classifies the unique pathophysiological phenotypes of patients with obesity, facilitating personalized healthcare solutions. By enabling healthcare centers to utilize precision medicine tools, Phenomix aims to improve the management of chronic diseases associated with obesity, offering better efficacy, reduced side effects, and lower costs.